Cargando…
Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review
Familial Hypercholesterolemia (FH) is an underdiagnosed condition in the United States (US) and globally, affecting an estimated 1/250 individuals. It is a genetic risk factor for premature cardiovascular disease and is responsible for an estimated 600,000 to 1.2 million preventable vascular events....
Autores principales: | Hendricks-Sturrup, Rachele M., Mazor, Kathleen M., Sturm, Amy C., Lu, Christine Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789613/ https://www.ncbi.nlm.nih.gov/pubmed/31266140 http://dx.doi.org/10.3390/jpm9030032 |
Ejemplares similares
-
Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2019) -
A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2020) -
Patient-Reported Outcomes following Genetic Testing for Familial Hypercholesterolemia, Breast and Ovarian Cancer Syndrome, and Lynch Syndrome: A Systematic Review
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2021) -
Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
por: Jones, Laney K., et al.
Publicado: (2020) -
A survey of United States adult privacy perspectives and willingness to share real-world data
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2023)